Back
Enlivex Therapeutics Stock Price Chart
My #1 Coin is...
All the details are on the next page.
Sell
20
ENLV
Enlivex Therapeutics
Last Price:
1.60
Seasonality Move:
-0.05%
7 Day Trial
ALL ACCESS PASS
$
7
This trade could move overnight Thursday!
Access my free presentation on these overnight trades right here- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ENLV is experiencing slight buying pressure.
Enlivex Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.57 | Buy |
| 20-day SMA: | 1.89 | Sell |
| 50-day SMA: | 2.99 | Sell |
| 200-day SMA: | 2.4 | Sell |
| 8-day EMA: | 1.61 | Buy |
| 20-day EMA: | 1.97 | Sell |
| 50-day EMA: | 2.54 | Sell |
| 200-day EMA: | 2.7 | Sell |
Enlivex Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.46 | Sell |
| Relative Strength Index (14 RSI): | 35.84 | Sell |
| Chaikin Money Flow: | 17422 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.13 - 3.51) | Sell |
| Bollinger Bands (100): | (1.94 - 3.76) | Sell |
Enlivex Therapeutics Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Enlivex Therapeutics Stock
Is Enlivex Therapeutics Stock a Buy?
- Enlivex Therapeutics share price is 1.62 while ENLV 8-day simple moving average is 1.57, which is a Buy signal.
- The stock price of ENLV is 1.62 while Enlivex Therapeutics 20-day SMA is 1.89, which makes it a Sell.
- Enlivex Therapeutics 50-day simple moving average is 2.99 while ENLV share price is 1.62, making it a Sell technically.
- ENLV stock price is 1.62 and Enlivex Therapeutics 200-day simple moving average is 2.40, creating a Sell signal.
ENLV Technical Analysis vs Fundamental Analysis
Sell
20
Enlivex Therapeutics (ENLV)
is a Sell
Is Enlivex Therapeutics a Buy or a Sell?
-
Enlivex Therapeutics stock is rated a Sell
The current Enlivex Therapeutics [ENLV] share price is $1.62. The Score for ENLV is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
Enlivex Therapeutics Stock Info
Market Cap:
30.48M
Price in USD:
1.62
Share Volume:
45.7K
Enlivex Therapeutics 52-Week Range
52-Week High:
4.59
52-Week Low:
1.15
Sell
20
Enlivex Therapeutics (ENLV)
is a Sell
Enlivex Therapeutics Share Price Forecast
-
What is the Enlivex Therapeutics stock price today?
The Enlivex Therapeutics stock price is 1.62 USD today. -
Will ENLV stock go up or go down?
Enlivex Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Enlivex Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Enlivex Therapeutics is overvalued.
Is Enlivex Therapeutics Stock a Buy?
- Enlivex Therapeutics share price is 1.62 while ENLV 8-day exponential moving average is 1.61, which is a Buy signal.
- The stock price of ENLV is 1.62 while Enlivex Therapeutics 20-day EMA is 1.97, which makes it a Sell.
- Enlivex Therapeutics 50-day exponential moving average is 2.54 while ENLV share price is 1.62, making it a Sell technically.
- ENLV stock price is 1.62 and Enlivex Therapeutics 200-day simple moving average is 2.70, creating a Sell signal.
Fundamental Analysis of Enlivex Therapeutics
Is Enlivex Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.06 per share, an increase this year of $0.50 per share, and an increase next year of $0.31 per share.
Technical Analysis of Enlivex Therapeutics
Should I short Enlivex Therapeutics stock?
- ENLV Moving Average Covergence Divergence (MACD) indicator is -0.46, suggesting Enlivex Therapeutics is a Sell
- Enlivex Therapeutics Relative Strength Index (RSI) is 35.84, which suggest Enlivex Therapeutics is oversold
- The Bollinger Bands (25) for Enlivex Therapeutics is (1.13 - 3.51), which suggest Enlivex Therapeutics is a Sell
- The Bollinger Bands (100) for Enlivex Therapeutics is (1.94 - 3.76), which suggest Enlivex Therapeutics is a Sell
* Enlivex Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.